Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals

Laura Testa North America Legal Chronicle
Tagged:

Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction.Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive merger…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here